Live News

Relationship of atherosclerotic lesion by optical coherence tomography with cholesterol efflux capacity by immobilized liposome-bound gel beads method

Effect of in-hospital initiation of alirocumab on clinical outcomes in Chinese ACS patients: findings from the Chinese Cardiovascular Association (CCA) Database-Chest Pain Center

Atherosclerosis

0 0

Real-world variability and factors associated with individual low-density-lipoprotein cholesterol response to different doses of atorvastatin, rosuvastatin, and simvastatin in 28,647 Chinese patients

Atherosclerosis

0 0

The Hidden Atherogenic Burden of Lipoprotein(a): Reclassification by Risk-Weighted ApoB in a Multicenter Registry

Atherosclerosis

0 0

Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions

Atherosclerosis

0 0

Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects

Atherosclerosis

0 0

The adventitia, vascular inflammation, and the intersection of hypertension and vascular disease

Atherosclerosis

0 0

Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development

Atherosclerosis

0 0

Deficiency of the aryl hydrocarbon receptor in intestinal epithelial cells, but not hepatocytes, ameliorates atherosclerosis development by sex-dependently targeting the lipid metabolism

Atherosclerosis

0 0

Lactate promotes macrophage-derived foam cell formation and atherosclerosis

Atherosclerosis

0 0

Tracking the infiltration of gold-labelled monocytes into live human atherosclerotic plaques: Spectral photon counting CT imaging analysis

Atherosclerosis

0 0

Inflammasome inhibition in myocardial infarction reduces early reperfusion injury and suppresses systemic plaque activation

Atherosclerosis

0 0

Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease

Atherosclerosis

0 0

Genome-wide cross-trait analysis reveals immunogenetic pleiotropy between autoimmune diseases and myocardial infarction and prioritizes therapeutic targets

Atherosclerosis

0 0

Universal paediatric screening for familial hypercholesterolaemia: Lessons learnt from our pilot study EARLIE

Atherosclerosis

0 0

Lp(a) testing and treatment with Lp(a)-lowering therapies in the primary and secondary prevention of cardiovascular disease in high income countries: A preliminary health technology assessment

Atherosclerosis

0 0

Hematopoietic loss of Y chromosome and risk of symptomatic peripheral artery disease in men

Atherosclerosis

0 0

Long-term average atherogenic index of plasma and cardiovascular mortality in 8.9 million Korean adults: A nationwide cohort study

Atherosclerosis

0 0

Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry

Atherosclerosis

0 0

The role of ANGPTL8 in metabolism and cardiovascular diseases: Consensus and controversy

Cardiovascular disease (CVD) is one of the leading causes of death and disease burden worldwide. With ongoing shifts in li...

Atherosclerosis

0 0

Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons

Emerging evidence from large observational studies and causal genetic studies suggest that elevated very-low-density lipop...

Atherosclerosis

0 0

OGT deficiency in vascular smooth muscle orchestrates foam cell formation and PANoptosis during atherosclerotic progression

Atherosclerosis is a chronic cardiovascular disease characterized by the accumulation of fibrous plaques in arterial walls...

Atherosclerosis

0 0

Post-transcriptional modifications on tRNA fragments confer functional changes to high-density lipoproteins in atherosclerosis

Background and aimsEpitranscriptomic RNA modifications play a crucial role in RNA processing, stability, and function. Sma...

Atherosclerosis

0 0

C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide. The initiation a...

Atherosclerosis

0 0

Heparin decreases serum sphingosine-1-phosphate levels in patients with vascular diseases

Volume 412, January 2026, 120593Author links open overlay panel, , , , , , , , , , , Highlights•Determinants of circulatin...

Atherosclerosis

0 0

Genome-wide gene-sleep interaction study identifies novel lipid loci in 732,564 participants

Volume 412, January 2026, 120603Author links open overlay panelRaymond Noordam a b ⁎ 1, Wenyi Wang c 1, Pavithra Nagarajan...

Atherosclerosis

0 0

Physical activity in carotid atherosclerotic patients blunts monocyte pro-inflammatory processes: a randomised controlled trial

Volume 412, January 2026, 120589Author links open overlay panelMathilde Mura a b, Amandine Thomas a, Michèle Weiss-Gayet c...

Atherosclerosis

0 0

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration

Background and aimsDiagnosis of Homozygous Familial Hypercholesterolaemia (HoFH) relies on untreated low-density lipoprote...

Atherosclerosis

0 0

Associations of long-term cumulative C-reactive protein and glycoprotein acetyls concentrations in childhood, adolescence and adulthood with adulthood retinal microvascular structure

Volume 412, January 2026, 120595Author links open overlay panel, , , , , , , , , , , , , , , , , Highlights•Long-term cumu...

Atherosclerosis

0 0

Categories

Channels

SCI Abstract